During the past decade, USARIEM conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 3 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "USARIEM" #1 collaborator was "ChromoLogic, LLC" with 1 trials as a collaborator, "Gaia Medical Institute" with 1 trials as a collaborator, "Intelligent Automation, Inc." with 1 trials as a collaborator, "Massachusetts Institute of Technology" with 1 trials as a collaborator and "US Army Combat Capabilities Development Command- Soldier Center" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "USARIEM" are "Glucose Metabolism" (2 trials), "Abnormal Blood Oxygen Pressure" (1 trials), "Acute Mountain Sickness" (1 trials), "Appetite" (1 trials) and "Blood Sugar Response" (1 trials). Many other conditions were trialed in "USARIEM" in a lesser frequency.

Most popular intervention types in "USARIEM" are "Other" (8 trials), "Dietary Supplement" (2 trials), "Drug" (2 trials), "Behavioral" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Acetazolamide" (1 trials), "Adequate Carbohydrate" (1 trials), "Dehydration" (1 trials) and "Eating rate" (1 trials). Other intervention names were less common.

The vast majority of trials in "USARIEM" are 12 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "USARIEM". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in USARIEM, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in USARIEM, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 11 trials that are defined as “Not Applicable".